Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT)

NCT07261150 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT07261150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07261150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT)
Lead sponsor
University of Minnesota
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
December 31, 2030
Enrollment
664 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

histoplasmosis